Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This study assessed the efficacy, safety, and tolerability of 2 doses of oral fingolimod (1.25 mg/day and 0.5 mg/day) compared to placebo in patients with relapsing-remitting multiple sclerosis (RRMS)
Epistemonikos ID: 1d222f8b87521d76f66f689cde8dd7c9e13c1266
First added on: Sep 11, 2014